CDBIO is a medical foundation based in the Republic of Seychelles that specializes in providing advanced molecular physics-based healthcare services. 

Yasama Yasuhiko (Yasama), the CEO of Idea International and a research co-worker at the Tohoku Univ Research and Analytical Center for Giant Molecular Studies, is currently serving as the CTO of the CDBIO Foundation. 

Their molecular sensors, which utilize lithium-resistant fullerene, are highly precise technologies capable of diagnosing diseases and monitoring health conditions based on medication effects. This cutting-edge medical technology enables customized prescriptions and treatments optimized for individual patient characteristics. 

Building upon this technology, CDBIO is developing the Molecular Medical & Healthcare Platform. This platform aims to create a unique blockchain healthcare ecosystem by combining the expertise of global molecular physics and electrochemical scholars with the collective intelligence of professional medical communities and patient communities. 

Through this molecular-medical/healthcare platform, CDBIO aims to contribute to human health by facilitating early disease diagnosis, providing personalized medical services, and promoting disease prevention and systematic health care.